Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil kinetics and function in normal human volunteers

American Journal of Hematology

Volumn 57, Issue 1, 1998, Pages 7-15

  Dale, David C ^a   Liles, W Conrad ^a   Llewellyn, Claire ^a   Price, Thomas H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Blood half life; GM CSF; Neutrophil kinetics and function

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CELL KINETICS; CELL MIGRATION; CELL PROLIFERATION; DRUG EFFECT; FEMALE; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; MALE; MITOSIS; NEUTROPHIL; NEUTROPHILIA; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RESPIRATORY BURST; TURNOVER TIME;

ADULT; BONE MARROW; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; CHEMILUMINESCENT MEASUREMENTS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION; LEUKOCYTE COUNT; LEUKOPOIESIS; LUMINOL; MALE; NEUTROPHILS; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031974729     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199801)57:1<7::AID-AJH2>3.0.CO;2-0     Document Type: Article

References (45)

1. Gasson JC: Molecular physiology of granulocyte-macrophage colony-stimulating factor. Blood 77:1131, 1991.
2. Dorr RT: Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony-stimulating factor. Clin Ther 15:19, 1993.
3. Hill ADK, Naama HA, Galvano SE, Daly JM: The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications. J Leuk Biol 58:634, 1995.
4. Nemunaitis J, Rabinowe S, Singer JW, Bierman PJ, Vose, JM, Freedman AS, Onetto N, Gillis S, Oette D, Gold M, Buckner D, Hansen JA, Ritz J, Appelbaum FR, Armitage JO, Nadler LM: Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324:1773, 1991.
5. Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassleth PA, Stadtmauer EA, Wiernik PH: A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: A study of the Eastern Cooperative Oncology Group (E1490). Blood 86:457, 1995.
6. Heil G, Chadid L, Hoelzer D, Seipelt G, Mitrou P, Huber C, Kolbe K, Mertelsmann R, Lindemann A, Frisch J, Nicolay U, Gaus W, Heimpel H: GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML). Leukemia 9:3, 1995.
7. Schuening FG, Neumunaitis J, Appelbaum FR, Storb R: Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials. Bone Marrow Transplant 14:S74, 1994.
8. Cairo MS, Christensen R, Sender LS, Ellis R, Rosenthal J, va de Ven C, Worcester C, Agosti JM: Results of a phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor in very low birth-weight neonates: Significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils. Blood 86:2509, 1995.
9. Badar'o R, Nascimento C, Carvalho JS, Badar'o F, Russo D, Ho JL, Reed SG, Johnson WD Jr., Jones TC: Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis. J Infect Dis 170:413, 1994.
10. Onyeji CO, Nightingale CH, Tessier PR, Nicolau DP, Bow LM: Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. J Infect Dis 172:810, 1995.
11. Lieschke MB, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28, 99, 1992.
12. Devereux S, Bull HA, Campos-Costa D, Saib R, Linch DC: Granulocyte macrophage colony-stimulating factor induced changes in cellular adhesion molecule expression and adhesion to endothelium: In vitro and in vivo studies in man. Br J Haematol 71:323, 1989.
13. Groopman JE, Misuyasu RT, DeLeo MJ, Oette DH, Golde DW: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 317:593, 1987.
14. Aglietta M, Piacibello W, Sanavio F, Stacchini A, Apra F, Schena M, Mossetti C, Carnino F, Caligaris-Cappio F, Gavosto F: Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor. J Clin Invest 83:551, 1989.
15. Chatta GS, Price TH, Allen RC, Dale DC: The effects of in vivo recombinant methionyl human granulocyte colony stimulating factor (rhG-CSF) on the neutrophil response and peripheral blood colony forming cells in healthy young and elderly volunteers. Blood 84:2923, 1994.
16. Price TH, Chatta GS, Dale DC: The effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 88:335, 1996.
17. Hansel TT, DeVries UM, Iff T, Rihs S, Wandzilak M, Betz S, Blaser K, Walker C: An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 145:105, 1991.
18. Price TH, Lee MY, Dale DC, Finch CA: Neutrophil kinetics in chronic neutropenia. Blood 54:581, 1979.
19. 32P-diisopropyl fluorophosphate for neutrophil kinetic studies. Acta Haematol 67:175, 1982.
20. Athens JW, Haab OP, Raab SO, Mauer AM, Ashenbrucker H, Cartwright GE, Wintrobe MM: Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest 40:989, 1961.
21. Price TH, Dale DC: Blood kinetics and in vivo chemotaxis of transfused neutrophils: Effect of collection method donor corticosteroid treatment and short term storage. Blood 54:977, 1979.
22. Wright DG, Meierovics, AI, Foxley JM: Assessing the delivery of neutrophils to tissues in neutropenia. Blood 67:1023, 1986.
23. Klebanoff SJ, Olszowski S, Van Voorhis WC, Ledbetter JA, Waltersdorph AM, Schlechte KG: Effects of γ-interferon on human neutrophils: Protection from deterioration on storage. Blood 80:225, 1992.
24. Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ: Cross-linking of CD45 enhances activation of the respiratory burst in response to specific stimuli in human phagocytes. J Immunol 155:2175, 1995.
25. Liles WC, Ledbetter JA, Waltersdorph AW, Klebanoff SJ: Cross-linking of CD18 primes human neutrophils for activation of the respiratory burst in response to specific stimuli: Implications for adhesion-dependent physiological responses in neutrophils. J Leuk Biol 58:690, 1995.
26. Daley M, Williams T, Coyle P, Furda G, Dougherty R, Hayes P: Prevention and treatment of staphylococcus aureus infections with recombinant cytokines. Cytokine 5:276, 1993.
27. Dale DC, Liles WC, Summer W, Nelson S: Granulocyte-colony-stimulating factor: Role and relatonships in infectious diseases. J Infect Dis 172:1061, 1995.
28. Lieschke GJ, Maher D, Cebon J, O'Conner M, Green M, Sheridan W, Boyd A, Rallings M, Bonnem E, Metcalf D, Burgess AW, McGrath K, Fox RM, Morstyn G: Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. Ann Int Med 110:357, 1989.
29. Dale DC, Fauci AS, Guerry D, Wolff SM: Comparison of agents producing a neutrophilic leukocytosis in man: Hydrocortisone, prednisone, endotoxin and etiocholanolone. J Clin Invest 56:808, 1975.
30. Vogel JM, Kimball HR, Wolff SM, Perry S: Etiochcholanolone in the evaluation of marrow reserves in patients receiving cytotoxic agents. Ann Intern Med 67:1226, 1967.
31. Herion JC, Walker RI, Herrin WB, Palmer JG: Effects of endotoxin and nitrogen mustard of leukocyte kinetics. Blood J Hematol 25:522, 1965.
32. Brans PP, Van der Lely N, Haanen C, Pennings AH, Boezeman JB, Wessels JM, Raijmakers RA, de Witte TJ: Cell kinetics of hematopoiesis before and after in vivo administration of GM-CSF in refractory anemia: Evidence for a shortening of the granulocyte release time. Ann Hematol 68:175, 1994.
33. Lopez AF, Williamson J, Gamble JR, Begley CG, Harlan JM, Kle- banoff SJ, Waltersdorph A, Wong G, Clark SC, Vadas M: Recombinant granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression and survival. J Clin Invest 78:1220, 1986.
34. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012, 1992.
35. Lord BI, Gurney H, Chang J, Thatcher N, Crowther D, Dexter T: Haemopoietic cell kinetics in humans treated with rGM-CSF. Int J Cancer 50:26, 1992.
36. Peters WP, Stuart A, Affronti ML, Kim CS, Coleman RE: Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans. Blood 72:1310, 1988.
37. Addison IE, Johnson B, Devereux S, Goldstone AH, Linen DC: Granulocyte-macrophage colony-stimulating factor may inhibit neutrophil migration in vivo. Clin Exp Immunol 76:149, 1989.
38. Liles WC, Rodger ER, Dale DC: Differential regulation of human neutrophil surface expression of CD14, CD11b, CD18, and L-selectin following the administration of G-CSF in vivo and in vitro. Clin Res 42:237a, 1994.
39. Repp R, Valerius T, Sendler A, Gramatzki M, Iro H, Kalden JR, Platzer E: Neutrophils express the high affinity receptor for IgG (FcγRI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 78:885, 1991.
40. Valerius T, Repp R, de Wit TPM, Berthold S, Platzer E, Kalden JR, Gramatzki M, van de Winkel JGJ: Involvement of the high-affinity receptor for IgG (FcγRI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood 82:931, 1993.
41. Kerst JM, de Haas M, van der School CE, Cortenbach IC, Kleijer M, von dem Borne AE, van Oers RH: Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: Induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood 82:3265, 1993.
42. Yong KL, Linen DC: Differential effects of granulocyte- and granulocyte-macrophage colony-stimulating factors (G- and GM-CSF) on neutrophil adhesion in vitro and in vivo. Eur J Haematol 49:251, 1992.
43. Hansen PB, Kjaersgaard E, Johnsen HE, Gram J, Pedersen M, Nikolajsen K, Hansen NE: Different membrane expression of CD11b and CD14 on blood neutrophils following in vivo administration of myeloid growth factors. Br J Haematol 85:50, 1993.
44. Weisbart R, Kwan L, Golde D, Gasson J: Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 69:18, 1987.
45. Balazovich KJ, Almeida HI, Boxer LA: Recombinant human G-CSF and GM-CSF prime human neutrophils for Superoxide production through different signal transduction mechanisms. J Lab Clin Med 118:576, 1991.